rethinkPeptides Search
Menu
Home / Research library
Study breakdown

IGF-1 Peptide Hydrogel Delivers Stem Cells to Heal Acute Kidney Injury

RPEP-051902020Wang, Hongfeng; Shang, Yuna; Chen, Xiaoniao; Wang, Zhongyan; Zhu, Dashuai; Liu, Yue; Zhang, Chuyue; Chen, Pu; Wu, Jie; Wu, Lingling; Kong, Deling; Yang, Zhimou; Li, Zongjin; Chen, Xiangmei
Animal StudyPreliminary evidence
The takeaway

A self-assembling peptide hydrogel incorporating the IGF-1C domain with D-amino acids improves stem cell survival and kidney repair in acute kidney injury.

Improved survival

MSCs delivered in IGF-1C peptide hydrogel showed enhanced engraftment and therapeutic efficacy in AKI

What the researchers found

An IGF-1C domain peptide hydrogel with D-amino acid stability enhancement improves MSC survival, engraftment, and therapeutic efficacy in acute kidney injury.

Why it matters

Stem cell therapy for kidney injury is limited by poor cell survival after transplantation. This peptide hydrogel solves that problem by creating a protective microenvironment.

The numbers in context

IGF-1C domain; D-form peptide; β-sheet self-assembly; enhanced angiogenesis; kidney function recovery

How the study worked

Self-assembling peptide hydrogel synthesis, MSC encapsulation and delivery, acute kidney injury mouse/rat model, histological and functional kidney assessments.

Who was studied

Mice with acute kidney injury (hP-MSC transplantation model)

What this study cannot tell us

Animal study. Long-term fate of MSCs in hydrogel not assessed. Translation to human kidney injury treatment needs clinical validation.

How to read the evidence

Animal study with functional outcome data. Strong preclinical evidence for hydrogel-enhanced stem cell therapy.

When this study was published

Published in 2020. Peptide hydrogels for regenerative medicine continue to advance.

The bigger picture

Bioactive peptide hydrogels that mimic growth factor signals while protecting transplanted cells could transform regenerative medicine across multiple organ systems.

Questions still open

  • Does the hydrogel persist long enough for complete kidney repair?
  • Could this approach work for chronic kidney disease?
  • Is the IGF-1C signaling essential or is the structural support sufficient?

Common questions

Why do stem cells need a hydrogel for kidney repair?
When stem cells are injected into damaged tissue, most die quickly without a supportive environment. The peptide hydrogel acts like scaffolding that protects cells, keeps them in place, and provides growth factor signals (IGF-1C) that help them survive and repair the kidney.
What makes this hydrogel special?
It combines a bioactive IGF-1C peptide that mimics growth factor signaling with D-form amino acids that make it resistant to enzymatic breakdown. This provides both biological function and structural stability.

Read the original research

Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.

International journal of nanomedicine, 15, 4311-4324

View on PubMed ↗Publisher’s paper ↗

Citation

Wang, Hongfeng; Shang, Yuna; Chen, Xiaoniao; Wang, Zhongyan; Zhu, Dashuai; Liu, Yue; Zhang, Chuyue; Chen, Pu; Wu, Jie; Wu, Lingling; Kong, Deling; Yang, Zhimou; Li, Zongjin; Chen, Xiangmei. (2020). Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.. International journal of nanomedicine, 15, 4311-4324. https://doi.org/10.2147/IJN.S254635